Allogene shareholders elect three Class I directors, approve say-on-pay, ratify auditor

Allogene Therapeutics, Inc.

Elizabeth Barrett, Arie Belldegrun, and David Chang elected as Class I directors with >131M votes for each.
Advisory vote on NEO compensation approved: 139.9M for, 14.2M against, 3.2M abstain.
Ratification of Ernst & Young as auditor for FY2025: 190.1M for, 414.6K against.
All proposals passed with no broker non-votes on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.